Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127265691 | 12726569 | 1 | I | 20160902 | 20160908 | 20160908 | PER | US-GLAXOSMITHKLINE-US2016GSK131190 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127265691 | 12726569 | 1 | PS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | U | 18644 | TABLET | |||||||||
| 127265691 | 12726569 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 0 | 2.25 | G | BID | |||||||
| 127265691 | 12726569 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 0 | 3 | G | BID | |||||||
| 127265691 | 12726569 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | 0 | 3.75 | G | BID | |||||||
| 127265691 | 12726569 | 5 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | U | 0 | |||||||||||
| 127265691 | 12726569 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 0 | ||||||||||
| 127265691 | 12726569 | 7 | C | Albuterol sulfate Inhalational powder | ALBUTEROL SULFATE | 1 | UNK | U | 0 | ||||||||||
| 127265691 | 12726569 | 8 | C | CHLORZOXAZONE. | CHLORZOXAZONE | 1 | UNK | U | 0 | ||||||||||
| 127265691 | 12726569 | 9 | C | ADDERALL XR | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | ||||||||||
| 127265691 | 12726569 | 10 | C | PROVIGIL | MODAFINIL | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127265691 | 12726569 | 1 | Product used for unknown indication |
| 127265691 | 12726569 | 2 | Narcolepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127265691 | 12726569 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127265691 | 12726569 | Depression | |
| 127265691 | 12726569 | Disturbance in attention | |
| 127265691 | 12726569 | Dysphonia | |
| 127265691 | 12726569 | Fatigue | |
| 127265691 | 12726569 | General physical health deterioration | |
| 127265691 | 12726569 | Libido decreased | |
| 127265691 | 12726569 | Memory impairment | |
| 127265691 | 12726569 | Myalgia | |
| 127265691 | 12726569 | Nausea | |
| 127265691 | 12726569 | Paraesthesia | |
| 127265691 | 12726569 | Pre-existing condition improved | |
| 127265691 | 12726569 | Therapeutic response unexpected | |
| 127265691 | 12726569 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127265691 | 12726569 | 2 | 201306 | 201306 | 0 | |
| 127265691 | 12726569 | 3 | 201306 | 201307 | 0 | |
| 127265691 | 12726569 | 4 | 201307 | 2014 | 0 | |
| 127265691 | 12726569 | 6 | 20130617 | 0 | ||
| 127265691 | 12726569 | 7 | 20130617 | 0 | ||
| 127265691 | 12726569 | 8 | 20130502 | 0 | ||
| 127265691 | 12726569 | 9 | 20160629 | 0 | ||
| 127265691 | 12726569 | 10 | 20130401 | 0 |